pI: 6.7004 |
Length (AA): 451 |
MW (Da): 49327 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128020)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G04710 | Zn-dependent exopeptidases superfamily protein |
Arabidopsis thaliana | AT5G60160 | zn-dependent exopeptidases superfamily protein |
Babesia bovis | BBOV_IV011550 | aspartyl aminopeptidase, putative |
Brugia malayi | Bm1_16690 | Aspartyl aminopeptidase |
Candida albicans | CaO19.9871 | similar to vacuolar aminopeptidase |
Candida albicans | CaO19.2335 | similar to vacuolar aminopeptidase |
Caenorhabditis elegans | CELE_F01F1.9 | Protein DNPP-1 |
Cryptosporidium hominis | Chro.30408 | hypothetical protein |
Cryptosporidium parvum | cgd3_3610 | possible aspartyl aminopeptidase |
Dictyostelium discoideum | DDB_G0286149 | aspartyl aminopeptidase |
Echinococcus granulosus | EgrG_001083400 | aspartyl aminopeptidase |
Entamoeba histolytica | EHI_106690 | aspartyl aminopeptidase, putative |
Entamoeba histolytica | EHI_021340 | aminopeptidase, putative |
Echinococcus multilocularis | EmuJ_001083400 | aspartyl aminopeptidase |
Homo sapiens | ENSG00000123992 | aspartyl aminopeptidase |
Leishmania braziliensis | LbrM.29.2330 | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 |
Leishmania donovani | LdBPK_292470.1 | aspartyl aminopeptidase, putative |
Leishmania infantum | LinJ.29.2470 | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 |
Leishmania major | LmjF.29.2360 | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 |
Leishmania mexicana | LmxM.08_29.2360 | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 |
Loa Loa (eye worm) | LOAG_13528 | hypothetical protein |
Loa Loa (eye worm) | LOAG_10667 | hypothetical protein |
Loa Loa (eye worm) | LOAG_04116 | aspartyl aminopeptidase |
Mycobacterium leprae | ML2213c | PROBABLE AMINOPEPTIDASE PEPC |
Mus musculus | ENSMUSG00000026209 | aspartyl aminopeptidase |
Mycobacterium tuberculosis | Rv0800 | Probable aminopeptidase PepC |
Neospora caninum | NCLIV_006860 | hypothetical protein |
Oryza sativa | 4351851 | Os12g0236500 |
Oryza sativa | 4324011 | Os01g0967900 |
Plasmodium berghei | PBANKA_0833100 | M18 aspartyl aminopeptidase, putative |
Plasmodium falciparum | PF3D7_0932300 | M18 aspartyl aminopeptidase |
Plasmodium knowlesi | PKNH_0731000 | M18 aspartyl aminopeptidase, putative |
Plasmodium vivax | PVX_087090 | M18 aspartyl aminopeptidase, putative |
Plasmodium yoelii | PY03205 | aspartyl aminopeptidase, putative |
Saccharomyces cerevisiae | YHR113W | Ape4p |
Schistosoma japonicum | Sjp_0060580 | ko:K01267 aspartyl aminopeptidase [EC3.4.11.21], putative |
Schistosoma mansoni | Smp_159960.2 | aspartyl aminopeptidase (M18 family) |
Schistosoma mansoni | Smp_159960.1 | aspartyl aminopeptidase (M18 family) |
Schmidtea mediterranea | mk4.004830.01 | Putative aspartyl aminopeptidase |
Trypanosoma brucei gambiense | Tbg972.3.3570 | aspartyl aminopeptidase, putative,metallo-peptidase, Clan MH, Family M20 |
Trypanosoma brucei | Tb927.3.3410 | aspartyl aminopeptidase, putative |
Trypanosoma brucei | Tb11.v5.0768 | aspartyl aminopeptidase, putative |
Trypanosoma congolense | TcIL3000_0_42510 | aspartyl aminopeptidase, putative |
Trypanosoma cruzi | TcCLB.508153.180 | aspartyl aminopeptidase, putative |
Trypanosoma cruzi | TcCLB.508183.4 | metallo-peptidase, Clan MH, Family M20 |
Theileria parva | TP01_1150 | aspartyl aminopeptidase, putative |
Trichomonas vaginalis | TVAG_115460 | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_392410 | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_490070 | Clan MH, family M18, aspartyl aminopeptidase-like metallopeptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu816 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.3.3410 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.3410 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.3410 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.3410 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0833100 | Plasmodium berghei | Dispensable | plasmo |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Plasmodium falciparum | M18 aspartyl aminopeptidase | Compounds | References |
Homo sapiens | aspartyl aminopeptidase | Compounds | References |
13 literature references were collected for this gene.